Each charge related to fraudulent pet insurance claims that Mr Johnston had made for the treatment of animals when he was in practice in Banbridge, County Down, two of which were fictitious, and where he had arranged for the insurance claims to be diverted and paid into a personal bank account, rather than the practice’s bank account.
At an initial hearing, which concluded on April 2022, Mr Johnston had admitted all the charges against him as well as admitting that his conduct was dishonest and amounted to serious professional misconduct.
The Committee was satisfied that his conduct amounted to serious professional misconduct, with Committee Chair Paul Morris saying: “The Committee has no hesitation in concluding that the respondent’s dishonest conduct will have severely undermined the confidence of the public in the veterinary profession and, further, that his conduct fell far short of the standards and conduct properly to be expected of a member of the veterinary profession.
"The Committee is satisfied that this conduct by the respondent brought the profession into disrepute.”
The proceedings were then adjourned to allow a psychiatric report and other mitigation to be prepared.
At its resumed hearing in November 2022 the Committee considered what sanction to impose in relation to Dr Johnston’s actions.
At this point, the Committee decided to postpone its decision on sanction for a period of two years on the condition that Dr Johnston enter into undertakings to the Committee including refraining from any form of gambling, subjecting himself to a close regime of support and supervision, and repaying some of the sums he had defrauded.
The hearing reconvened in October 2024 to decide on an appropriate sanction.
The Committee noted that Mr Johnston had complied with the undertakings and provided the Committee with the interim reports required of him.
He also continued with the therapeutic interventions and programmes specified, as well as implemented measures designed to minimise the risk of a relapse into gambling.
The Committee also noted that reports from the gambling support services, to which Mr Johnston had signed up, all spoke positively about his involvements and confirmed the progress he had achieved in managing his addiction.
The Committee also took into account a psychiatric report as well as evidence under oath from Mr Johnston’s wife who confirmed his compliance with the undertakings.
As a result, the Committee was satisfied that the prospects of a repeat of the conduct which led to the charges laid against Dr Johnston were now greatly reduced.
The Committee said it was less impressed with the evidence provided by Mr Johnston.
While he had largely complied with the letter of the undertakings he gave in 2022, it remained troubled by his apparent unwillingness or inability, on account of lack of effort, to fulfil the assurances previously given that he was in the process of changing his name to Johnston, from Fegan, on official documentation in order to be consistent with his legal name, when he had not done so.
The only formal name change in place was on the RCVS Register, and he had failed to alter his name on his driver’s licence, on his registration with the Veterinary Council of Ireland, his passport, bank accounts, and one of his email addresses.
As a result, the Committee did not find Dr Johnston to be an entirely satisfactory witness.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Having made the progress that he has over the period since the commission of the charges found proved in 2019, the Committee considers that the imposition of a sanction of suspension on top of the period of postponement would be excessive, in the particular circumstances of this case.
“For the same reasons, as stated above, it is considered that it would be excessive now to impose a sanction of removal from the register.
“That process of reasoning has driven the Committee to the conclusion that the sanction of a reprimand and warning as to future conduct is what the facts and circumstances of this case call for.
"That is because the respondent can be under no illusion about the outcome were he to appear again before this Committee.
"A failure to take advantage of the exceptional course adopted by this Committee on this occasion would be regarded as a serious aggravating factor were he to appear before the Committee at any time in the future.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
According to Intervet, a study undertaken in Germany last summer has proven the efficacy of Butox SWISH at killing the midges responsible for carrying the bluetongue virus, when applied monthly to cattle. The study showed that even brief contact between a midge and hair from a treated animal killed midges rapidly for up to four weeks post-treatment.
The standard dose, applied in the usual way (on the neck and topline of the animal) delivers full-body coverage of Butox SWISH’s deltamethrin, helped partly by its unique micronised formulation. The product is also highly lipophilic which means it binds onto the natural oil secretions of the coat helping to improve coverage.
The trial used six heifers (each weighing around 400kg) treated with 30ml Butox SWISH (the standard fly dose and method of application). Two un-treated heifers were also studied for comparison.
During the five week period, contact between midges and treated hair caused immediate paralysis, and the midges then died at varying intervals depending on contact time and the number of days post-treatment with Butox SWISH. The trial verified the application of Butox SWISH monthly at the standard dose for cattle.
Trial director, Professor Mehlhorn suggested that producers should be prepared to reduce vector contact by removing their breeding habitats and combining this with the use of a knock-down treatment like Butox SWISH, which is the only product of its type which has proven efficacy against midges. Used in conjunction with vaccination, these measures may not stop the disease entering the herd, but will help reduce the spread of disease.
The new Aberdeen clinic will be based at Ardene House Veterinary Hospital, Kingswells in Aberdeen and will provide the out-of-hours cover for a number of veterinary practices in the Aberdeen area, treating their clients' pets at nights, weekends and bank holidays.
Vets Now was founded in 2001 when vet Richard Dixon, saw a gap in the market for not only providing an alternative to the 'on call' service which vets are required to provide by the Royal College of Veterinary Surgeons, but to providing a dedicated emergency service for pets, similar to A & E for humans. Vets Now now treats around 100,000 small animal emergencies every year with clinic teams working purely out-of-hours, to ensure that they are always fresh and ready to provide life saving treatment to pets who are injured or critically ill.
Richard said: "Vets Now has a clinic in Edinburgh and we have recently opened the first of our Vets Now Hospitals in Glasgow which combines emergency care with a range of specialist referral options, serving the whole of Scotland so we're looking forward hugely to extending our service in Scotland by bringing the dedicated emergency service to Aberdeen."
Vets Now will be working with Ardene House Veterinary Hospital, Abervet, Ashgrove Veterinary Centre, Bridge Veterinary Group and Swan Veterinary Practice to deliver their Out Of Hours emergency care.
Veterinary practices who would like to find out more about using the new Vets Now service in Aberdeen should contact Vets Now on 01383 620064.
US-based Life Technologies has launched a new PCR-based test system which, according to the company, allows large numbers of pigs to be screened more quickly and cost-effectively for a range of common pathogens, such as PRRSV, SIV and PCV2.
The system uses samples of oral fluids which can be obtained by leaving a cotton rope in each pen for pigs to chew on. After 20 minutes or so, the rope can be retrieved and the saliva and gingival crevicular fluid squeezed into a sample bag and represents a pooled sample from the group.
Studies have demonstrated that oral fluid samples collected in this way can form the basis of a quick and cost-effective method for screening a range of common viral pathogens. The samples were tested using a commercially available sample preparation and real-time PCR test system which can isolate and identify viral nucleic acid in a matter of hours.
For PRRS, pooled samples of oral fluids were collected from groups of experimentally infected pigs using the rope technique, along with serum samples from each individual pig on the same days. Both serum samples and oral fluids were processed using the same Applied Biosystems preparation system and real- time PCR test, both of which were supplied by Life Technologies. The results showed that PRRSV nucleic acid was detectable in both serum and oral fluid samples from the day of infection through to 40 days after infection.
For PCV2, 24 pigs that were free of PRRSV and SIV were divided into 4 pens in separate rooms, and challenged with two different virus strains (PCV2a and PVC2b) at different times. One pen acted as a (non-challenged) control. Oral fluids were collected regularly up to 140 days after initial challenge and tested using real-time PCR. High titres of PCV2 were detected from day 12 to day 28 post infection and virus was detectable throughout the entire testing period (days 2 to 98).
For SIV, a total of 180 spiked oral fluid samples were tested using real-time PCR, and subtyping reagents were also used to identify haemagglutinin and neuraminidase subtypes. The results showed that SIV nucleic acid was detectable in oral fluid samples spiked with high, medium and low copy numbers of SIV, and all positive samples could be successfully sub-typed.
Christina Boss, European Professional Service Veterinarian for Life Technologies said: "Collecting samples in this way is far less invasive for the pigs and so avoids unnecessary stress. And because all of the pigs will chew on the rope, it provides a very broad sample from the group, which is the key to assessing overall herd health. In addition, if the pooled sample provides a positive result, then the animals in that pen can be tested individually to identify those that are infected.
"These results show that the simplicity of oral fluid sampling, combined with the speed and sensitivity of a PCR-based system, provides a practical and cost- effective way of monitoring large numbers of pigs for common virus pathogens.
"The use of a semi-automated, PCR-based diagnostic system means that nucleic acid purification can be achieved in just 25 minutes and results from the real-time PCR available in 90 minutes. The molecular test is very specific and reliable, so the veterinarian can initiate individual testing as quickly as possible and make confident recommendations to the producer."
According to Life Technologies, screening for PRRS using samples of oral fluids has been gaining popularity over recent years because large numbers of pigs can be tested without increased cost or labour. The new research is due to be presented as a poster at the ESPHM meeting in Bruges in April.
The RCVS has appointed Amanda Boag as its new Treasurer, replacing Dr Bradley Viner who will become (junior) Vice-President in July.
Amanda will officially take up her post at RCVS Day - the College's Annual General Meeting and Awards Day - on Friday 11 July.
Amanda is a Clinical Director at Vets Now and is also currently President of the European Society of Veterinary Emergency and Critical Care. She was elected to RCVS Council for a four-year term in 2012.
As Treasurer she will be responsible for maintaining an overview of the College's affairs, ensuring its financial viability and making sure that proper financial records and procedures are maintained.
Amanda said: "I am very honoured to have been appointed Treasurer for the RCVS and am looking forward to working closely with other Council members and the Belgravia House team.
"I would particularly like to thank my predecessor Bradley Viner for the excellent work he has done over the past four years. This has been a period of great change for the College and during his tenure he has done a huge amount of work to support the improvements in governance, including standardising the way that the College's accounts are reported.
"Our finances are currently in a healthy state despite no increase in the annual renewal fee for several years. I am now looking forward to building on his legacy and ensuring the finances remain healthy, allowing us to move forward with our Strategic Plan."
At RCVS Day on 11 July, Professor Stuart Reid will also be confirmed as President; current President Neil Smith as (senior) Vice-President; Chris Tufnell as Chairman of the Education Committee; and David Catlow as Chairman of the Standards Committee.
If you're in London before January 6th 2008, the Animal's War exhibition at the Imperial War Museum might be worth a visit. Sponsored by The Kennel Club and PetPartners, the family exhibition explores the remarkable role of animals in conflict from the First World War to the present day using hands-on interactives, photographs, film and sound clips, paintings, touchable sculptures, and memorabilia from the Imperial War Museum collections and private and public lenders from all over the world.
Graham Gardner has launched its summer collection of scrubwear in the form updated versions of its Urbane and Easiphit Collections, with new colour combinations added to the range.
The Urbane Collection, pictured right, is designed specifically for the female form. Easiephit is a contempary unisex collection.
Simon Ward, Sales Director said: "Scrubwear is becoming a firm favourite with veterinary staff in the UK. The relaxed comfort offered by scrubs is very attractive to staff, and the smart image of colour coded garments is very well received by managers seeking a unified department look. With the increased stocks and increased colour combinations, customers can now get their hands on the new uniforms more quickly than ever before!"
Other colour combinations are still available as special imports. Non-stocked colour requests will be directed to Grahame Gardner's USA Partners and the sales team will ensure that customers are kept updated as to delivery times.
Both Easiephitt and Urbane have also increased their stocked size range. Grahame Gardner now aim to hold sizes from extra, extra small to extra, extra large.
For further information on Urbane, Easiephitt or Grahame Gardner Ltd, please call 0116 255 6326, or visit http://www.grahamegardner.co.uk/.
The RCVS is to hold an online hustings on Tuesday, 19 March at 7pm to help voters decide who they wish to vote for in the upcoming RCVS Council elections, and is inviting members of the veterinary profession to suggest questions for the candidates to answer.
Gordon Hockey, RCVS Registrar said: "From feedback we've received, one of the reasons why people don't vote is because they know little about the candidates or their views. We hope this hustings will provide the candidates with a platform to address the veterinary electorate directly, and give voters the chance to put their own questions to those hoping to serve on Council."
The hustings will be run as a live webinar by 'The Webinar Vet' and will be free to listen to. However, the College says that due to the high number of candidates standing for election, it isn't possible to hold a debate, so questions should be submitted in advance (see below). Each candidate will be allocated around three minutes to introduce themselves and answer up to three questions of their choosing. The whole event will run for just under an hour.
Anthony Chadwick, who runs The Webinar Vet, will moderate proceedings, and Gordon Hockey will be on-hand to address any factual inaccuracies.
Veterinary surgeons can register to listen to the hustings at www.thewebinarvet.com/rcvs and submit their questions at the same time; alternatively, questions can be emailed to Ian Holloway at the RCVS (i.holloway@rcvs.org.uk).
Questions should be relevant to the role of the RCVS and the role of Council Members (see www.rcvs.org.uk/about). If questions should remain anonymous, please say so.
Ballot papers and candidates' biographies and manifestos are due to be posted on 7 March. Votes may be cast online, by text message or by post, by 5pm on Friday, 26 April 2013.
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Intervet/Schering-Plough Animal Health has produced a new Orf Vaccination Starter Pack to help vets better inform their sheep farmer clients about the disease.
The new campaign Vaccination Starter Pack includes a practical guide to Orf and its control in UK sheep flocks, a DVD profiling vet and farmer experiences of managing the disease, an 'Orf questions answered' handout and a best practice vaccination protocol. Additional practice support materials highlighting the problems caused by Orf and its control with Scabivax Forte are also available.
The Starter Pack and full range of promotional materials are available from local Intervet/Schering-Plough Account Managers or by contacting the Veterinary Support Group on 01908 685685.
Merial has joined forces with the Global Alliance for Rabies Control (GARC) promote its "Me and My Dog - Together Against Rabies" social media campaign, designed to raise awareness of the importance of vaccinating dogs against rabies.
As part of the campaign, pet owners are asked to share photos of themselves with their dog on social media channels, using the hash tags #TogetherAgainstRabies and #MerialMeAndMyDog.
Merial says the increased numbers of pets travelling since the changes to the Pet Travel Scheme rules in 2012 means that awareness of rabies amongst pet owners is important, despite the fact that the disease is not endemic in the UK.
Joanne Maki, Director Veterinary Public Health for Wildlife and Companion Animals for Merial said: "The "Me and My Dog - Together against Rabies" campaign is a unique opportunity for all of us to play a part in spreading the word about eliminating human rabies through the vaccination of animals. The more of us who participate, the stronger we are in this important fight".
Improve International has announced that it is to launch new 'mini-modular' courses in dentistry, oncology, neurology and ultrasound for those practitioners that want to develop a more in-depth knowledge than they would gain from a one-day course without undertaking a Certificate.
The courses, which begin in the Autumn, include two days of study each month for three months, making six days of CPD in total. Ultrasound delegates study for two days each month for two months, making four days of CPD in total. Each course, with the exception of Neurology, contains a practical element.
David Babington MRCVS, Managing Director of Improve, said: "Veterinary surgeons wanting to develop specialist skills in specific areas currently have two choices - either to embark on a full-scale Certificate programme or to attend one day sessions in their area of interest. For those without the time or resource to commit to a Certificate programme but who are keen to develop their skills to a high level, attending a one-day course may not give them the expertise - or the practical experience - they seek."
He continued: "Our Mini-Modular courses aim to bridge that gap. They are high quality programmes, led by recognised international experts, and each gives a thorough grounding in the subject, specifically geared to the requirements of the small animal general practitioner. They aim to give delegates in-depth knowledge, practical experience and the confidence to take their new skills back into practice."
The Mini-Modular courses are open to veterinary surgeons from across Europe with teaching based at Improve's training headquarters in Swindon, which offer wet-lab facilities.
For further information, visit www.improveinternational.com or call 01793 759159.
RCVS Knowledge says it first identified the need for an open access and easily accessible means of distributing veterinary evidence in early 2014. The concept for a new digital journal was announced at the 2014 EBVM Network Conference, and began with the mission statement of improving front-line clinical standards, funded initially by a donation from the RCVS.
In its first year Veterinary Evidence has published 58 papers which have been downloaded over 34,000 times by an international audience spanning 20 countries. It has also streamlined its submission process and added a range of new tools and resources. The tools include a downloadable submission template and a range of checklists and guidelines to help the practitioner conduct evidence-based medicine.
Looking to the future, the charity says that its website platform will be overhauled later in 2017, so practitioners can find articles quickly and implement their findings in practice.
RCVS Knowledge is now running a survey to find out what topics you'd like to see covered by Veterinary Evidence. All participants will entered into a draw for a new iPad.
Veterinary Evidence is also on the hunt for a new Editor-in-Chief, to move the journal into its next chapter. The Editor-in-Chief will have a passion for EBVM and engaging with the veterinary community and will help provide readers with the content they need. If you’re interested in applying for this role you can view the full job description here.
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
Reference
Amanda originally studied and worked in Australia where she undertook a residency in small animal medicine at Murdoch University, completing a Masters in respiratory medicine in dogs.
She moved to the UK in 2016 to work in referral medicine, joining Hamilton Specialist Referrals in 2024 as head of its medicine service.
The webinar will include a refresher on the bacterial, fungal, parasitic and protozoal causes of lower respiratory tract disease and its pathology, after which it will look at techniques and methods for diagnosis.
Amanda's presentation will also look at the secondary effects of infectious lower respiratory disease pathogens, and prescribing and management options.
https://horiba.link/respiratory-disease-in-dogs-and-cats
Researchers at the University of Edinburgh’s Royal (Dick) School of Veterinary Studies are to start testing whether a compound of cooling chemicals, extracted from mint, can be used to treat laminitis, a condition which affects seven per cent of the British horse population.
The new project, funded by The Horse Trust and led by Professor Sue Fleetwood-Walker, builds on recent work that revealed for the first time that, there is significant nerve damage, as well as inflammation, within the hoof of laminitic horses. This explains why anti-inflammatory drugs are so ineffective in treating the pain of chronic laminitis and highlights the need for therapies to treat nerve injury-induced or ‘neuropathic’ pain in horses.
Prof Fleetwood-Walker’s team discovered in 2006 that the ‘mint’ chemicals have a pain–killing effect in laboratory studies of chronic pain. They will now investigate whether this synthetic treatment could help horses with laminitis.
VetCell is celebrating a win at Cheltenham, after 'Knowhere' won the Cotswold Chase following pioneering stem cell treatment for a serious tendon injury.
Knowhere had had a good start to his racing career as a four-year-old, winning his first two races as a novice hurdler. But after his second race in 2004 he suffered injuries to both forelimb superficial digital flexor tendons. The left fore showed low grade tendonitis while the right fore had a significant percentage of fibre rupture. As a promising racing prospect, Knowhere’s connections wanted to give him the best possible chance of recovering from his injury so they opted for stem cell therapy. He was treated by Tim Beauregard MRCVS of Summerhill Farm in Gloucestershire.
Bone marrow samples were collected from Knowhere’s sternum and were processed in VetCell's laboratory over a five week period to generate millions of stem cells. Knowhere was sedated, the tendon area was anaesthetised and the leg was then surgically clipped and disinfected. Stem cells, which had been suspended in serum obtained from the original bone marrow sample, were then injected using ultrasound guidance, into the core of the damaged area of the tendon fibres.
For the first week after the implantation Knowhere was kept in his stable to allow the cells to adapt to their new environment. Each day after this he was given walking exercise in order to stimulate the activity of the stem cells, encouraging them to differentiate into tendon cells and form into strong tendon fibres. The amount of exercise was incrementally increased, building up over a three-month period from five minutes each day to 45 minutes twice a day.
By the autumn of 2005 both of Knowhere’s tendons had healed very well and showed good fibre pattern on ultrasonography. He was re-introduced to the racetrack the following year and of the 15 or so races he has been in since, he has finished in the frame on eight occasions and has amassed some £175,000 in winnings.
Vet Tim Beauregard said: “Knowhere’s successful return to the track has been exciting and immensely satisfying to follow and he showed particularly brilliant form in the Cotswold Chase. It remains to be seen whether he will be heading for the Ryanair Chase, the Gold Cup or the Grand National but all involved will be hoping for the best.”
For more information please contact VetCell on +44 207 691 2062 or 866 764 0340, email: info@vetcell.com or visit the website at http://www.vetcell.com/
The Veterinary Medicines Directorate has published the results of the distribution category review, which has recommended the re-classification of 50 products from POM-V or POM-VPS to a less restrictive distribution category.
Not all the products recommended for reclassification will be reclassified, as in some cases, the Marketing Authorisation Holder (MAH) has declined.
MAH will change the distribution category from POM-V to NFA-VPS:Advantage Spot-on Solution for dogs, cats, small cats, small dogs and pet rabbitsDuowinScalibor Protectorband for dogsTop Drop Spot-on Solution for dogs
MAH will change the distribution category from POM-V to POM-VPS:Alpha Ject 2-2Aquavac FNM Plus VaccineAquavac FurovacFurogen 2LactovacLeptavoid HNobilis CAV P4ParacoxParacox 5 oral suspensionRotavec CoronaSpirovacSuvaxyn Ery
MAH will change the distribution category from POM-VPS to AVM-GSL:Coprite
MAH will change the distribution category from POM-V to AVM-GSL:Rearguard
MAH has decided not to change the distribution category from POM-V to NFA-VPSAdvantix Spot-on Solution for dogsFleegard for dogs / cats Frontline Combo spot on for cat and dogFrontline SprayTop Drop
Those Marketing Authorisation Holders that have indicated they are content with the recommendations are required to submit a variation to change the distribution category for the products involved by 30th June 2010, and the variations will come into force at the next label reprint.
For the full report, and a complete list of the affected products, please visit the VMD website here.
Vets Now has this month launched a new fast track programme called 'Cutting Edge', which the company says is aimed at young, dynamic vets.
The 'Cutting Edge' initiative is apparently the first training programme of its kind in the UK and will see 40 graduates who graduated between 2006 and 2009 recruited into a 10 week fast track training programme, before they take up permanent positions in Vets Now clinics. Each recruit will get a salary package which will put them on £40k within 24 months.
Interviews and selection will be held mid-late August at a number of selection centres across the UK, with the first intake of 20 recruits commencing their fast track training programme on 4 October and taking up their positions in a Vets Now clinic in December.
A second intake of recruits to the programme will be selected during November, with these recruits taking up their positions on the fast track training late in January.
The programme is being spearheaded by Vets Now Clinical Director and experienced clinician and teacher in Emergency and Critical Care, Amanda Boag, MA VETMB DipACVIM DACVECC FHEA MRCVS who said: "This is a unique and hugely exciting opportunity for recently qualified vets to enter the field of Emergency and Critical Care. We're looking for dynamic and energetic young vets with a real passion for continuing their clinical development who feel they have what it takes to succeed in this exciting, and growing sector of veterinary medicine."
She added: "The recruits who we select will embark upon an intensive period of training over the 10 week period which will give them the necessary skills and knowledge to launch their career in ECC. They will also receive ongoing support during their first two years as a veterinary surgeon in a Vets Now clinic with a very generous CPD allowance. The initial 10 week period will be a combination of lectures and interactive seminars, practical training in our clinical skills laboratory and mentored work in our clinics. Developing clinical expertise and problem solving skills will clearly be the most significant component of the training but there will also be support and training in other vital skills including communication."
Until now, Vets Now would only employ veterinary surgeons with at least two years post-qualified small animal experience or who have completed their PDP. This new programme has been launched to attract and support young talent in making the move to this growing sector of veterinary medicine.
Recent graduates who are interested in developing a career in ECC are invited to apply in the first instance by contacting the Vets Now recruitment team on 01383 841181 or by emailing cuttingedge@vets-now.com.
The new initiative also has a Facebook page - www.facebook.com/vetsnowcutting edge and you can follow news and updates on the 'Cutting Edge' Twitter page at www.twitter.com/vncuttingedge.
Petplan has been named the UK's Best Pet Insurance Provider at the Consumer Moneyfacts awards.
Voted for by over 17,000 consumers, the awards recognise the best financial products available to consumers in the UK.
Petplan, which says it has recently strengthened its policies to provide pet owners with more comprehensive cover, was chosen by consumers for its market leading policies and outstanding customer service.
Petplan Director Neil Brettell said: "The award is great recognition for the fantastic job that our team at Petplan does to keep pets healthy and owners happy.
"Our Covered for Life policies truly do what they say, they ensure that a pet can get the best possible treatment throughout its life without the owner having to worry about the cost. It's great to be recognised for the service that we've been providing to the nation's pets for over 35 years."
For information about how working with Petplan can help your practice call Vetline on 0800 316 8800 or visit www.petplanvet.co.uk
The International Veterinary Epilepsy Task Force (IVETF), a group of 26 veterinary practitioner, neuropharmacology, neuropathology and neurology experts led by Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC, has issued new guidelines for treating and caring for dogs with epilepsy.
The guidelines have been adopted by the American College of Veterinary Internal Medicine (ACVIM) and published in the form of a ‘consensus statement’ in the Journal of Veterinary Internal Medicine (JVIM).
Professor Volk, who co-chaired the consensus statement process, said: "I was honoured to have been asked to co-chair such an important forum in American veterinary practice. This will be another landmark paper to help improve the care vets deliver for the patients with epilepsy, both in America and beyond.
"Epilepsy is one of the most common neurological diseases encountered by veterinary surgeons and practitioners around the world. The prevalence of the condition means there have been numerous research studies carried out over the years. But, despite such frequent research, there has been a lack of consistency when it comes to diagnosis and treatment.
"This lack of cohesion and collaboration made it difficult for owners and veterinary professionals to communicate effectively on the issue of pet epilepsy. This has led to the global veterinary community changing its approach and, in recent years, working more closely together."
Professor Volk says the aim of these latest guidelines is to provide joined up and collaborative thinking, teaching and learning on various different aspects of the condition that specifically affect America. These include the development of treatment strategies and any potential issues with chronic anti-epileptic drug treatment.
The ACVIM guidelines follow on from seven in-depth consensus statements produced by the IVETF and published open access in BMC Veterinary Research last year, outlining recommendations and classifications on all aspects of canine epilepsy. It was the first time this many veterinary neurology clinicians and neuroscientists formally agreed on the key aspects of the condition.
Professor Volk, who is also the Clinical Director of the RVC’s Small Animal Referral Hospital, added: "There is a real exciting buzz around canine and feline Epilepsy currently. Finally getting to global consensus from the international veterinary community will accelerate research and lead to improved patient care and quality of life for owners and patients alike."
The company is now asking farm vets to point their clients in the direction of the FarmComm study and encourage them to take part, share their thoughts and help shape the way we all work together in the future.
Mat Yarnall, senior brand manager at Boehringer said: "With routine visits, practice meetings, herd or flock health planning sessions and farming shows and exhibitions all on-hold, how vets work with their clients is subject to change on a scale never seen before.
“The study is striving to understand what methods of working going forward may work, what won’t work and how people want to work.”
The FarmComm study will be being sent out directly to farmers or can be accessed at https://bit.ly/farm-comm.
Matt added: "Following analysis and interpretation, these findings will be shared with vets as we all move together into new and different times."
The RCVS ERP provides an ethics review mechanism for researchers who are based in practice and don't have access to this process through university and industry connections.
The subcommittee has representation across a range of areas of veterinary expertise, including veterinary nursing, and also includes lay researchers and scientists.
Since its formation as a trial service in 2016, the ERP has reviewed more than 530 research proposals on behalf of the College.
Nicola said: “I am honoured to be offered this position.
"Having been a member of RCVS ERP for the past three years and undertaking a similar role as the Chair of the Clinical Research Ethical Review Board at the Royal Veterinary College, I felt that I had the right expertise to take on the role
“It is vitally important that all research, regardless of where it is undertaken, undergoes ethical review to ensure that robust results are produced especially when they have the potential to influence clinical practice, and so I really welcome the work the ERP has been undertaking.
“As chair of the ERP I hope to build on the success of my predecessor and continue to support those working in clinical practice that is not associated with a university to undertake valuable research and add to the body of evidence that supports our clinical decision-making.”
www.rcvs.org.uk/ethics
Siemens will be showcasing its range of technology for veterinary care, from advanced ultrasound, CT and MRI systems to haematological and immunological diagnostics at BSAVA Congress.
The company says MRI and CT are starting to become more influential in the veterinary field. MRI provides a reliable veterinary imaging method when traditional procedures such as X-ray and ultrasound are not able to convey the detail needed. They display small changes in bone and soft tissue and can be complemented with special adjustments such as mini coils for dog and cat paws to make them suitable for application with animals. This allows vets to diagnose more accurately and treat specific complaints. The images produced by MRI systems can be used for tumour diagnosis, nervous complaints or orthopaedic problems as well as intestinal, respiratory or cardiovascular disorders.
Siemens will also be presenting its in vitro range of solutions and assays in chemistry, haematology and immunology.
This will include the IMMULITE® range, a blood testing platform which the company says has an unrivalled immunoassay portfolio, allowing the rapid diagnosis of a broad spectrum of small animal conditions.
Information on the ADVIA® 2120i Haematology System with specific animal software and Dimension® Xpand® Plus integrated chemistry and immunoassay system will also be available.
Product literature and in-depth discussions with Siemens specialists will be available from the stand during the event.
The RCVS has announced that the first members of its reconstituted Disciplinary and Preliminary Investigation Committees have been appointed and will join the Committees from July 2013.
Beverley Cottrell and Catherine Goldie (pictured right) have been appointed to the new Disciplinary Committee (DC), and are retiring as elected veterinary surgeons on Council to take up the posts. Veterinary surgeons Jane Downes and Charles Gruchy, and lay members Stuart Drummond, Ian Green, Chitra Karve and Mehmuda Mian, will also join the DC.
The new Preliminary Investigation Committee (PIC) members will include veterinary surgeons Andrew Ash and William Reilly, plus lay members Penny Howe, Sarah Pond and Elana Tessler.
These new appointments result from a legislative reform order (LRO) made to separate the RCVS disciplinary committees from the RCVS Council. The Royal College says this will improve the independence of the disciplinary process and bring it into line with regulatory best practice.
The LRO came into force on 6 April 2013, and amended the Veterinary Surgeons Act 1966 (VSA). The VSA now requires that the RCVS PIC and DC are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently. The change to the legislation ensures that the same group of people is not responsible for setting the rules, investigating complaints, and adjudication.
The LRO also brings lay people formally into the PIC and will increase the pool of people available to investigate complaints and sit on disciplinary hearings.
RCVS Registrar and Head of Legal Services, Gordon Hockey said: "The LRO fundamentally improves the way the veterinary profession is regulated, and will help to ensure public confidence in our disciplinary processes. I am delighted by the constructive and collaborative working relationship that we had with Defra and the British Veterinary Association (BVA), which has allowed this major reform to be introduced."
To make these appointments, a long-list of lay and veterinary surgeon candidates was put together by recruitment consultants, and a shortlist was referred to an independent selection committee chaired by Sir Michael Buckley and including Christopher Laurence and Dr Joan Martin. The selection committee's choices were then ratified by RCVS Council at the June 2013 meeting.
As part of a transition phase, both committees will also include some Council members; after a two-year period, members of RCVS Council will become ineligible for membership of either committee.